高级搜索
CD20+B和CD3+T淋巴细胞在乳腺浸润性导管癌和髓样癌中的表达及与预后的关系[J]. 肿瘤防治研究, 2013, 40(05): 463-467. DOI: 10.3971/j.issn.1000-8578.2013.05.013
引用本文: CD20+B和CD3+T淋巴细胞在乳腺浸润性导管癌和髓样癌中的表达及与预后的关系[J]. 肿瘤防治研究, 2013, 40(05): 463-467. DOI: 10.3971/j.issn.1000-8578.2013.05.013
Expressions of CD20+B and CD3+T Lymphocytes in Infiltrating Ductal Carcinoma and Medullary Carcinoma and Their Relationships with Prognosis[J]. Cancer Research on Prevention and Treatment, 2013, 40(05): 463-467. DOI: 10.3971/j.issn.1000-8578.2013.05.013
Citation: Expressions of CD20+B and CD3+T Lymphocytes in Infiltrating Ductal Carcinoma and Medullary Carcinoma and Their Relationships with Prognosis[J]. Cancer Research on Prevention and Treatment, 2013, 40(05): 463-467. DOI: 10.3971/j.issn.1000-8578.2013.05.013

CD20+B和CD3+T淋巴细胞在乳腺浸润性导管癌和髓样癌中的表达及与预后的关系

Expressions of CD20+B and CD3+T Lymphocytes in Infiltrating Ductal Carcinoma and Medullary Carcinoma and Their Relationships with Prognosis

  • 摘要: 目的 检测CD20+B、CD3+T淋巴细胞在乳腺浸润性导管癌和髓样癌中的表达分布,探讨淋巴细胞浸润与浸润性导管癌预后的关系。方法 利用免疫组织化学链霉素亲和素生物素法检测128例浸润性导管癌,44例髓样癌中CD20、CD3的表达,分析表达差异与预后的关系。组间采用Kruskal-Wallis Test,组内采用卡方检验进行分析。结果 (1)CD20+B、CD3+T这两种淋巴细胞在浸润性导管癌中分布均是瘤周多于瘤内,在髓样癌中淋巴细胞表达高于浸润性导管癌(P<0.05)。(2)浸润性导管癌中CD20+B、CD3+T淋巴细胞浸润越多,无病生存率越高(P<0.05)。(3)CD20+B淋巴细胞与组织学分级、肿瘤pTNM分期、淋巴结状态、复发情况呈负相关(P<0.05);CD3+T淋巴细胞与组织学分级、淋巴结状态、复发状态呈负相关(P<0.05)。结论 CD20+ B、CD3+ T淋巴细胞在浸润性导管癌和髓样癌中表达差异有显著性,在浸润性导管癌中其浸润程度与预后相关。

     

    Abstract: Objective To detect the expression and distribution of CD20+B and CD3+T lymphocytes in breast cancer, discuss the relationship between the prognosis of breast cancer and lymphocyte infiltration. Methods Using immunohistochemistry(IHC) to investigate the expression of CD20 and CD3 in 44 medullary carcinoma cases and 128 cases of infiltrating ductal carcinoma, the relationship between the expression differences and prognosis was analyzed, Kruskal-Wallis Test was used among groups, Chi-square Test was used within the group. Results (1)There was a higher numbers of CD20+B lymphocytes and CD3+T lymphocytes in medullary carcinoma than that in infiltrating ductal carcinoma (P<0.05). Both of CD20+B lymphocytes and CD3+T lymphocytes located in peritumoral were more than that in intratumoral of infiltrating ductal carcinoma.(2)The higher numbers of CD20+B lymphocytes and CD3+T lymphocytes was associated with the longer disease-free survival in infiltrating ductal carcinoma(P<0.05).(3)CD20+B lymphocytes was negatively correlated with tumor grade,pTNM,nodal stage and recurrence(P<0.05);CD3+T lymphocytes was negatively correlated with tumor grade,nodal stage and recurrence(P<0.05). Conclusion There are different expression of CD20+B and lymphocytes CD3+T lymphocytes in infiltrating ductal carcinoma,and medullary carcinoma and the lymphocytes was associated with prognosis.

     

/

返回文章
返回